The rewiring of multiple essential metabolic pathways including glycolysis, lipid metabolism and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has been discovered to be associated with a more aggressive leukemic phenotype and drug resistance in AML (12–14). Here, GAPDH is linked to acute myeloid leukemia.